What the GLP-1 evidence establishes The GLP-1 category rests on two mechanisms: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide
Insurance coverage for tirzepatide varies among providers, but major players like United Healthcare, Blue Cross Blue Shield, and Cigna may cover this weight loss medication under specific conditions
High-quality, research-backed B12 formulations
Belkoff helps every patient choose the optimal therapy based on labs, history, and target outcome
Its rational
Researchers have proposed that GLP-1 receptors present in cardiac tissue may contribute to improved endothelial function, reduced inflammation, and favorable effects on blood pressure and lipid profiles, though these mechanisms remain hypothetical and require further investigation